InvestorsObserver
×
News Home

Is Karuna Therapeutics Inc (KRTX) a Stock to Watch After Losing -3.32% This Week?

Monday, March 20, 2023 12:46 PM | InvestorsObserver Analysts

Mentioned in this article

Is Karuna Therapeutics Inc (KRTX) a Stock to Watch After Losing -3.32% This Week?

The market has been high on Karuna Therapeutics Inc (KRTX) stock recently. KRTX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Karuna Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on KRTX!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With KRTX Stock Today?

Karuna Therapeutics Inc (KRTX) stock is lower by -6.77% while the S&P 500 is higher by 0.45% as of 12:31 PM on Monday, Mar 20. KRTX is down -$12.97 from the previous closing price of $191.63 on volume of 1,098,087 shares. Over the past year the S&P 500 is down -11.81% while KRTX is higher by 53.92%. KRTX lost -$8.74 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Karuna Therapeutics Inc click here.

More About Karuna Therapeutics Inc

Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues. Click Here to get the full Stock Report for Karuna Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App